Pedersson, Philip Rüssell
Skaarup, Kristoffer Grundtvig
Lassen, Mats Christian Højbjerg
Olsen, Flemming Javier
Iversen, Allan Zeeberg
Jørgensen, Peter Godsk
Biering-Sørensen, Tor
Funding for this research was provided by:
Copenhagen University
Article History
Received: 27 September 2023
Accepted: 8 January 2024
First Online: 16 February 2024
Declarations
:
: T.B.S. reports: Steering Committee member of the Amgen financed ‘GALACTIC-HF’ trial. Chief investigator and steering committee chair of the Sanofi Pasteur financed ‘NUDGE-FLU’ trial. Chief investigator and steering committee chair of the Sanofi Pasteur financed ‘DANFLU-1’ trial. Chief investigator and steering committee chair of the Sanofi Pasteur financed ‘DANFLU-2’ trial. Steering Committee member of ‘LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific’s Investigational ICM System’ trial. Advisory Board: Sanofi Pasteur, Amgen, and GSK. Speaker Honorarium: Novartis, Sanofi Pasteur, and GSK. Research grants: GE Healthcare and Sanofi Pasteur. K.G.S reports: Advisory Board: Sanofi Pasteur. P.G.J reports: Speaker Honorarium from Astra Zeneca. The remaining authors have nothing to disclose.
: Written informed consent was obtained from all patients. The retrospective study was performed in accordance with the 2nd declaration of Helsinki and approved by the regional ethics committee.